Project Grant HT94252410896
Award Date
11/1/24
Completion Date
10/31/26
Dollars Obligated
$400K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Chicago, IL 60612, USA
Similar Awards
This $366,000 federal Project Grant award, titled "VALIDATION OF A NONOPIOID ANALGESIC PATHWAY IN HUMAN SENSORY GANGLIA AND SPINAL CORD," was issued on September 15, 2024 by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The award was granted to the University of Florida to conduct advanced biomedical research focused on transforming healthcare for military service members and the broader public. The research will explore innovative...
This federal Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) provides $909,532.00 to The University of Texas Southwestern Medical Center to conduct research on validating a nonopioid analgesic pathway in human sensory ganglia and spinal cord. The award has a performance period from September 15, 2024 to September 14, 2025. The research aims to explore innovative, non-opioid based approaches to pain management, which is a...
This $1,394,919 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports the development of nonopioid analgesics to treat chronic pain. The University of Texas Health Science Center at San Antonio (UTHSCSA), a state-controlled research institution, is the prime grantee and will conduct this 3-year research project from August 2024 to July 2027. As a leading academic medical center, UTHSCSA will leverage its expertise in...
The Defense Health Agency awarded a $2,206,031 project grant to Rush University Medical Center to fund the PREVENTING THE DEVELOPMENT OF CHRONIC PAIN: TREATING PTSD AT ACUTE PAIN ONSET program. The grant is part of the Military Medical Research and Development program (CFDA 12.420) and will support basic, applied, and advanced biomedical research to transform military and public health care through innovative medical solutions for battlefield injuries. Specifically, the grant will fund...
Duke University was awarded a $1,608,140 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from September 1, 2022 to August 31, 2026 to develop non-opioid G protein-coupled receptor signaling-biased agents for pain management. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research with the goals of transforming military and...
This federal Project Grant award of $170,712.00 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports research on the comparative effectiveness of exercise, cognitive behavioral therapy, and their combination for individuals with chronic musculoskeletal pain and poor sleep. The award, with a period of performance from September 30, 2024 to September 29, 2028, is funding research conducted by the University of Queensland in Australia. The...
This federal Project Grant award of $442,750.00, provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports research at the University of California, Davis to determine the role of histone lactylation in post-traumatic osteoarthritis and arthritic pain. The award period runs from February 1, 2025 to January 31, 2027 and aims to advance biomedical research with potential to transform healthcare for military service members and the...
This federal Project Grant award, totaling $1,012,894.00, was issued by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to investigate pain reprocessing therapy for veterans with chronic back pain. The 4-year award, with a start date of September 30, 2024, will compare the efficacy of this therapy and examine facilitators and barriers to implementation. The University of Colorado-Denver is the prime awardee, with sub-awards going to Texas...
This federal Project Grant award of $602,900.00 was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant will fund a study comparing cognitive behavioral therapy and acupuncture for managing chronic pain, titled "COMPARING COGNITIVE BEHAVIORAL THERAPY AND ACUPUNCTURE FOR MANAGING CHRONIC PAIN (COMBAT-PAIN)". The award was made to The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., a...
The Defense Health Agency awarded a $2,528,000 Project Grant to the University of California, San Diego under the Military Medical Research and Development federal grant program (CFDA 12.420) to support research titled "MULTIPLEXED IN VIVO EPIGENOME ENGINEERING FOR THERAPEUTIC TARGETING OF CHRONIC PAIN." The four-year project beginning June 1, 2022 will investigate medical solutions for chronic pain through innovative epigenome engineering research with the goal of transforming...